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Traumatic Brain Injury in Later Life
Increases Risk for Parkinson Disease
Raquel C. Gardner, MD,1,2 James F. Burke, MD,3 Jasmine Nettiksimmons, PhD,2,4
Sam Goldman, MD, MPH,1,2 Caroline M. Tanner, MD,1,2 and
Kristine Yaffe, MD1,2,4,5
Objective: Traumatic brain injury (TBI) is thought to be a risk factor for Parkinson disease (PD), but results are con-
flicting. Many studies do not account for confounding or reverse causation. We sought to address these concerns by
quantifying risk of PD after TBI compared to non-TBI trauma (NTT; defined as fractures).
Methods: Using inpatient/emergency department (ED) International Classification of Disease, Ninth Revision code
data for California hospitals from 2005–2006, we identified patients aged 55 years with TBI (n552,393) or NTT
(n5113,406) and without baseline PD or dementia who survived hospitalization. Using Kaplan–Meier estimates and
Cox proportional hazards models (adjusted for age, sex, race/ethnicity, income, comorbidities, health care use, and
trauma severity), we estimated risk of PD after TBI during follow-up ending in 2011. We also assessed interaction
with mechanism of injury (fall vs nonfall) and effect of TBI severity (mild vs moderate/severe) and TBI frequency (1
TBI vs >1 TBI).
Results: TBI patients were significantly more likely to be diagnosed with PD compared to NTT patients (1.7% vs
1.1%, p< 0.001, adjusted hazard ratio [HR]5 1.44, 95% confidence interval [CI]5 1.31–1.58). Risk of PD was similar
for TBI sustained via falls versus nonfalls (interaction p50.6). Assessment by TBI severity (mild TBI: HR5 1.24, 95%
CI5 1.04–1.48; moderate/severe TBI: HR51.50, 95% CI51.35–1.66) and TBI frequency (1 TBI: HR51.45, 95%
CI5 1.30–1.60; >1 TBI: HR51.87, 95% CI5 1.58–2.21) revealed a dose response.
Interpretation: Among patients aged 55 years presenting to inpatient/ED settings with trauma, TBI is associated
with a 44% increased risk of developing PD over 5 to 7 years that is unlikely to be due to confounding or reverse
causation.
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Incidence of traumatic brain injury (TBI) peaks 3 timesover the lifespan: in childhood, in adolescence, and in
older adulthood.1 Some prior studies have implicated
any lifetime history of TBI as a risk factor for Parkinson
disease (PD),2–4 the second most common neurodegener-
ative disease of aging. Other studies, however, have found
no such association and raise the hypothesis that recall
bias or reverse causation may contribute to the positive
reported associations.5,6 Whether TBI sustained in older
adulthood increases short-term risk of PD is a question
that has proven particularly difficult to approach. Specifi-
cally, when evaluating risk of PD following TBI sustained
in older adulthood—at a time when the cause of injury
is overwhelmingly due to falls7,8—it becomes increasingly
likely that the patient fell and sustained the TBI due to
early motor symptoms of PD rather than the reverse.
In this study, we sought to quantify risk of PD
after recent TBI sustained in older adulthood. To miti-
gate potential confounding and reverse causation, we
compared patients with TBI to those with other types of
non-TBI trauma (NTT; eg, fracture). Even among
patients who sustain TBI or NTT due to falls, however,
it is conceivable that those who fall and sustain a head
injury are more likely to have incipient PD due to slower
reaction times and reduced ability to redirect the fall tra-
jectory or break the fall with their a’rms.9 Thus, to
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further mitigate potential reverse causation, we assessed
for interactions with mechanism of injury. To further
enhance causal inference, we assessed the role of age, TBI
severity, TBI frequency, and time lag from trauma to PD
diagnosis. We hypothesized that younger patients may be
more resilient to the effects of mild TBI.8 We hypothe-
sized that TBI would increase risk for PD in a dose-
dependent manner (greater for severe TBI compared to
mild TBI; greater for multiple TBIs compared to single
TBI). Furthermore, we hypothesized that although the
estimated risk might be attenuated by excluding patients
with falls or PD diagnoses soon after trauma (as these
populations may be enriched for incipient PD), the effect
would persist, thereby supporting a causal association
between TBI and PD.
Patients and Methods
Design
This is a retrospective cohort study of administrative health
data using the State Inpatient Databases (SID)10 and State
Emergency Department Databases (SEDD)11 for the state of
California, managed by the Healthcare Cost and Utilization
Project (HCUP) and Agency for Healthcare Research and
Quality. The SID and SEDD capture all inpatient and emer-
gency department (ED) discharge diagnoses for participating
states for each year. For certain states/years, the HCUP has
linked each patient’s data with subsequent inpatient or ED vis-
its, thus allowing for longitudinal tracking of individual
patients. Data are then deidentified and are available to
researchers for a fee after completing a data use agreement. Cal-
ifornia was selected for this analysis as it is the most populous
state and had linked data available from 2005 to 2011.
Protocol Approval
The study was approved by the University of California, San
Francisco Human Research Committee, and the need for
informed consent was waived due to the use of deidentified
administrative data.
Patients
Adults 55 years old were included in the cohort if they were
diagnosed with TBI or NTT during an inpatient or ED visit in
2005 or 2006, did not die during the hospitalization, and did
not have a diagnosis of PD or dementia in any discharge diag-
nosis field.
Exposure
TBI was defined using Centers for Disease Control and Preven-
tion (CDC) criteria12,13: International Classification of Dis-
eases, Ninth Revision, Clinical Modification (ICD-9-CM)
800.0–801.9, 803.0–804.9, 850.0–854.1, or 959.01 in any dis-
charge diagnosis field. Mild TBI was defined according to
CDC criteria13: ICD-9-CM first 4 digits 800.0, 800.5, 801.0,
801.5, 803.0, 803.5, 804.0, 804.5, 850.0, 850.1, 850.5, or
850.9 (with a fifth digit of 0, 1, 2, 6, 9, or missing) or 854.0
(with a fifth digit of 1, 2, 6, 9, or missing). Moderate/severe
TBI was defined as all nonmild TBI. NTT was defined as frac-
ture, excluding fractures of the head and neck: ICD-9-CM
807.0–807.9, 812–819.9, 822–822.9, or 823–827.9. Patients
with both TBI and NTT during the same hospital visit were
classified as TBI. We classified patients with multiple subse-
quent hospital visits based on their first visit only such that a
patient who received a diagnosis of leg fracture during hospital
visit 1 but received a diagnosis of TBI during hospital visit 2
was classified as NTT.
Outcome
The primary outcome was a diagnosis of PD (ICD-9-CM
332.0) made during a subsequent ED visit or inpatient hospi-
talization during the follow-up period ending in 2011. The
follow-up in this study was comprised of all subsequent ED vis-
its or inpatient hospitalizations that were recorded in the
HCUP California SID or SEDD after the baseline visit for TBI
or NTT. This allowed for a maximum follow-up of 5 to 7 years
from the initial hospital visit for trauma. To further reduce the
chance of reverse causation, patients were excluded if the diag-
nosis of PD was made <1 year after the trauma.
Covariates
Information was collected on age, sex, race/ethnicity, comorbid-
ities (depression,14 delirium,15 drug/alcohol/tobacco disorders,
and vascular risk factors including hypertension, hyperlipid-
emia, diabetes, coronary artery disease, peripheral vascular dis-
ease, and cerebrovascular disease), trauma mechanism, health
care use, and trauma severity. ZIP Code–based median income
quartile provided by the HCUP was included as a proxy for
socioeconomic status.16 Comorbidities were based on ICD-9
discharge codes from the index visit for each patient as
described previously8 with the addition of tobacco disorders/
dependence ICD-9-CM 305.1. Trauma mechanism was coded
using major external cause of injury group codes (E codes)17
and then divided into 4 categories: falls, vehicle accidents,
assault, and other/unknown. An additional binary variable was
generated denoting falls versus nonfalls. Health care use data
included total hospital visits and total trauma visits per patient
during the follow-up period including the index visit, as well as
the location of the index visit (ED or inpatient). Trauma sever-
ity was defined according to the new injury severity score18 as
described previously.8
Primary Data Analysis
All statistical analyses were performed using Stata 13.1.19 Sum-
mary statistics were generated for baseline characteristics and
demographics of TBI and NTT groups and compared using t
test or chi-square test. Initial unadjusted estimates of risk of PD
after TBI versus NTT were calculated using Kaplan–Meier esti-
mates. Patients were not censored at death, as this information
was not provided by the HCUP and deidentification precluded
linkage to national death data. To evaluate the impact of poten-
tial confounders, we used Cox proportional hazard models
adjusted for all covariates listed above (age category [defined as
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TABLE 1. Baseline Characteristics of Patients with TBI versus NTT
Characteristics NTT, n5 113,406 TBI, n5 52,393 p
Age, yr 70.9 (10.9) 73.4 (11.1) <0.001
55–64 40,355 (35.6) 14,653 (28.0)
65–74 27,892 (24.6) 11,553 (22.1)
75–84 29,265 (25.8) 15,784 (30.1)
851 15,894 (14.0) 10,403 (19.9)
Women 76,705 (69.3) 29,603 (57.3) <0.001
Race/ethnicity <0.001
White 75,797 (66.8) 34,558 (66.0)
African American 3,860 (3.4) 2,033 (3.9)
Hispanic 14,747 (13.0) 6,271 (12.0)
Asian 4,163 (3.7) 3,318 (6.3)
Other/missing 14,839 (13.1) 6,213 (11.9)
Median income quartile <0.001
1st, poorest 25,746 (23.2) 10,276 (20.2)
2nd 26,856 (24.2) 12,184 (23.9)
3rd 29,811 (26.9) 14,327 (28.1)
4th, wealthiest 28,436 (25.6) 14,132 (27.8)
ICD-9 comorbidities at index visit
Hypertension 34,820 (30.7) 18,139 (34.6) <0.001
Hyperlipidemia 10,759 (9.5) 4,909 (9.4) 0.447
Diabetes 15,398 (13.6) 7,193 (13.7) 0.404
Coronary artery disease 8,971 (7.9) 5,143 (9.8) <0.001
Peripheral vascular disease 1,319 (1.2) 581 (1.1) 0.335
Cerebrovascular disease 2,416 (2.1) 2,007 (3.8) <0.001
Depression 3,483 (3.1) 1,576 (3.0) 0.486
Delirium 413 (0.36) 228 (0.44) 0.030
Drug disorder/dependence 433 (0.38) 170 (0.32) 0.071
Alcohol disorder/dependence 1,239 (1.1) 1,142 (2.2) <0.001
Tobacco use 3,668 (3.2) 1,423 (2.7) <0.001
Trauma mechanism <0.001
Fall 75,352 (66.4) 34,831 (66.5)
Vehicle accident 9,886 (8.7) 7,448 (14.2)
Assault 827 (0.7) 1,585 (3.0)
Other/missing 27,341 (24.1) 8,529 (16.3)
Health care use
Index visit location5ED 77,128 (68.0) 35,767 (68.3) 0.298
Total inpatient or ED visits 5.0 (6.4) 5.4 (7.2) <0.001
Total inpatient or ED visits for TBI/trauma 1.33 (0.7) 1.31 (0.7) <0.001
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55–64 years, 65–74 years, 75–84 years, or 85 years and older],
sex, race/ethnicity, income, comorbidities, trauma mechanism,
health care use, and new injury severity score). The time meta-
meter for the Cox models was time since the index visit for
TBI or NTT.
Additional Analyses
We tested for an interaction between TBI and trauma mechanism
(falls, vehicle accidents, assault, and other/unknown) as well as
between TBI and falls (falls vs nonfalls). We assessed the role of
time lag from trauma to PD diagnosis by conducting separate
analyses after excluding cases of PD diagnosed <1 year (primary
analysis), 2 years, or 3 years after TBI or NTT. We assessed the
roles of TBI severity and TBI frequency by using an expanded
TBI variable in a single Cox model (NTT vs mild TBI vs moder-
ate/severe TBI and NTT vs 1 TBI vs >1 TBI). To test for a sig-
nificant dose response for mild versus moderate/severe TBI and 1
versus >1 TBI (defined as a repeat TBI anytime during the study
period), we used the Wald test. To test our hypothesis regarding
age and TBI severity, we assessed for an interaction between age
category and TBI severity as well as specifically between age cate-
gory and mild TBI.8 In a preplanned sensitivity analysis to
account for loss to follow-up for any reason (including death), we
excluded PD-free TBI and NTT patients whose last ED or inpa-
tient visit recorded in the database was >1 year before the end of
the follow-up period (defined as the period from the index visit
until December 31, 2011). To account for potential misdiagnosis
of secondary parkinsonism as PD or vice versa, we performed a
final sensitivity analysis in which we excluded patients with a
diagnosis of secondary parkinsonism (ICD-9-CM 332.1) at any
time during the study period.
Results
Primary Analysis
A total of 165,799 cases of trauma were identified who
did not have baseline PD or dementia and who did not
die during the index hospitalization, and 52,393 (32%)
had TBI. Compared to the NTT patients, TBI patients
were slightly older, were more likely to be male, were
from higher income regions, had more comorbidities,
and had higher injury severity scores (Table 1). Trauma
was caused by falls in approximately 66% of both NTT
and TBI patients. Median follow-up was 6 years (inter-
quartile range5 5.5–6.5 years). After exclusion of cases
of PD that were diagnosed <1 year after TBI (n5 884),
a total of 2,126 cases of PD were identified during the
follow-up period. Patients with TBI were more likely to
be diagnosed with PD compared to patients with NTT
(1.7% of TBI patients vs 1.1% of NTT patients,
p< 0.001; Fig 1). Patients with TBI were diagnosed with
PD slightly sooner than those with NTT (average time
to PD diagnosis5 3.1 years vs 3.3 years, p5 0.02).
Overall, patients diagnosed with PD had a mean age (at
index visit) of 76 years (range5 55–95, standard
deviation5 8.6), were 59% female, and were 68% white.
In the unadjusted model, TBI was associated with a
56% increased risk of PD diagnosis (Table 2). Individual
adjustment for covariates changed the hazard ratio (HR)
by <10%, except for age category. In the fully adjusted
model (adjusted for age category, sex, race/ethnicity,
income, comorbidities, trauma mechanism, health care
use, and injury severity), TBI was associated with 44%
increased risk of PD diagnosis (see Table 2). Results were
similar if age was modeled as a continuous rather than a
categorical variable.
Additional Analyses
In fully adjusted models, there was no interaction identi-
fied between trauma mechanism (defined as fall, vehicle
accident, assault, or other/missing) and TBI status
TABLE 1: Continued
Characteristics NTT, n5 113,406 TBI, n5 52,393 p
New injury severity score 5.0 (3.7) 7.8 (5.9) <0.001
TBI severity at index visit <0.001
Mild TBI N/A 11,799 (22.5)
Moderate/severe TBI N/A 40,594 (77.5)
TBI frequency <0.001
1 TBI anytime during study period 5,950a (5.3) 44,733 (85.4)
>1 TBI anytime during study period 1,101a (1.0) 7,660 (14.6)
Values are mean (standard deviation) or No. (%). Total inpatient or ED visits are mean per participant over follow-up period
including index visit.
aThese patients were diagnosed with NTT at the index visit and then had subsequent ED or inpatient visit(s) for TBI.
ED5 emergency department; ICD-95 International Classification of Diseases, Ninth Revision; N/A5 not applicable;
NTT5 non-TBI trauma; TBI5 traumatic brain injury.
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(interaction p5 0.21) or between trauma mechanism and
TBI severity (interaction p5 0.38). Varying the time lag
from trauma to PD diagnosis or including only trauma
due to falls or only trauma due to nonfalls produced
results essentially identical to the primary analysis (Fig
2). Furthermore, there was a significant dose response
identified for TBI severity and TBI frequency such that
risk of PD following more severe or more frequent TBI
was doubled compared to that of mild or single TBI (see
Fig 2). There was no interaction identified between age
category and TBI severity (interaction p5 0.18) or spe-
cifically between age category and mild TBI, after exclud-
ing moderate/severe TBI cases (interaction p5 0.77). In
a preplanned sensitivity analysis designed to account for
loss to follow-up for any reason (including death) by
excluding non-PD patients without a visit in the database
within 1 year of the end of follow-up, results were simi-
lar to the primary analysis (fully adjusted HR5 1.55,
95% confidence interval (CI)5 1.41–1.70, p< 0.001).
Lastly, to account for potential misdiagnosis of secondary
parkinsonism as PD or vice versa, after excluding all
patients with a diagnosis of secondary parkinsonism at
any time during the study period (n5 5, of whom 1 also
had a diagnosis of PD), results were identical to the pri-
mary analysis (fully adjusted HR5 1.44, 95%
CI5 1.31–1.58).
Discussion
Among middle-aged and older patients diagnosed with
trauma in an ED or inpatient setting, we found that
there is a 44% increased risk of being diagnosed with
PD over the subsequent 5 to 7 years after TBI compared
to NTT. Furthermore, we found that risk is significantly
higher with more severe or more frequent TBI, lending
additional weight to a causal association.
This study is novel due to the use of NTT controls
as a means to reduce possible confounding and reverse
causation if patients with incipient PD are more likely to
fall and sustain a TBI than healthy controls. The success
of this approach is highlighted by our finding that
approximately 66% of trauma was caused by falls in
both the TBI and NTT groups. Furthermore, we found
that risk of PD after TBI due to falls versus nonfalls is
TABLE 2. Primary Analysis Cox Models Showing
Risk of PD after TBI versus NTT
HR 95% CI p







Fully adjusted model is adjusted for age, sex, race/ethnicity,
income, comorbidities, trauma mechanism, health care use,
and injury severity score.
CI5 confidence interval; HR5 hazard ratio; NTT5 non-
TBI trauma; PD5 Parkinson disease; TBI5 traumatic brain
injury.
FIGURE 2: The role of time lag from trauma to Parkinson
disease (PD) diagnosis, trauma mechanism (falls vs nonfalls),
traumatic brain injury (TBI) severity, and TBI frequency.
Excluding PD diagnosis rendered <1 year (primary analysis),
<2 years, or <3 years after trauma led to essentially equiva-
lent results. Analyzing only trauma due to falls versus only
trauma due to nonfalls produced equivalent results (p-value
in figure is for interaction term for TBI 3 fall). Risk of PD
after moderate/severe TBI was significantly greater than
risk of PD after mild TBI (p-value in figure is for Wald test).
After excluding non-TBI trauma (NTT) cases who went on to
suffer a TBI and then stratifying TBI cases by those with
only 1 TBI versus those who went on to suffer an additional
TBI during the study period, risk of PD after >1 TBI was sig-
nificantly greater than risk of PD after 1 TBI (p-value in fig-
ure is for Wald test). Error bars are 95% confidence
intervals (CIs). HR5hazard ratio.
FIGURE 1: Kaplan–Meier plot showing Parkinson disease
(PD)-free survival after traumatic brain injury (TBI) versus
non-TBI trauma (NTT). TBI is associated with increased risk
of PD compared to NTT. The Kaplan–Meier plot is adjusted
for age. [Color figure can be viewed in the online issue,
which is available at www.annalsofneurology.org.]
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equivalent. This finding suggests that even if some
patients who fall and sustain TBI are more likely to have
incipient PD due to slower reaction times9 that may pre-
dispose to head rather than bodily injury, then the
impact on the results is negligible. Additionally, the evi-
dence for a dose response for increasing TBI severity and
TBI frequency, and our persistently significant results
despite multiple additional analyses, all enhance causal
inference.
These results are in line with a recent meta-analysis
of 22 studies that reported a pooled odds ratio of 1.57
for the association between PD and head trauma.4 In
this meta-analysis, despite variability in methodological
approach and statistical significance, nearly all (19 of 22)
studies reported odds ratios> 1. Aside from mounting
evidence for an association between TBI and PD, many
prior studies have identified TBI as an important risk
factor for late onset dementia20–23 and possibly early
onset dementia as well.24 Together, this body of work
suggests that TBI may be an important risk-magnifier or
threshold lowerer for neurodegeneration of many kinds.
The risk of PD following mild TBI in particular has
been somewhat less clear. Results of the few prior studies
on this topic have been mixed. For example, of the 5
qualifying studies analyzed in a systematic review of the
literature from 1990–2012,5 only 2 reported an elevated
risk of PD after mild TBI.6,25 Interestingly, the authors of
one of these studies attributed these results to reverse cau-
sation6; the authors of the other study, to suboptimal
matching of controls.25 Our study appears to be among
the largest to date to specifically assess the risk of PD fol-
lowing mild TBI while mitigating both of these prior
methodological concerns. In our analysis of >11,000
patients with mild TBI compared to >113,000 patients
with NTT, we identified >1,300 subsequent cases of PD.
Patients with mild TBI were 24% more likely to develop
PD than those with NTT. The lack of an interaction
between age category and mild TBI indicates that risk of
PD following mild TBI is similar across ages.
PD is a progressive neurodegenerative disorder
characterized by loss of pigmented dopaminergic neurons
of the substantia nigra as well as the presence of abnor-
mal alpha-synuclein–containing Lewy bodies and Lewy
neurites.26 Prior to development of clinically apparent
parkinsonism, patients must lose upwards of 60% of
striatal dopamine.27 A causal association between TBI
and PD may be explained by several possible mecha-
nisms. First, TBI may produce a static brain injury that
reduces motor reserve, thereby leading to an earlier diag-
nosis of PD in a susceptible patient (eg, by unmasking
otherwise subclinical symptoms). Second, TBI may
actively accelerate or augment a pre-existing neurodege-
nerative cascade. Third, TBI may trigger a de novo neu-
rodegenerative cascade. Our results could theoretically
lend support to the first 2 hypotheses, but the relatively
short period of follow-up precludes commentary regard-
ing the third hypothesis.
A number of prior studies using animal models of
TBI support a causal mechanism for post-TBI PD. For
example, a study of experimentally induced TBI in rats
showed 15% loss of dopaminergic neurons ipsilateral to
the injury just 11 days after injury that increased to 30%
bilateral dopaminergic neuron loss 26 weeks postinjury.28
Others have shown persistently decreased markers of dopa-
mine synthesis and abnormal accumulation of alpha-
synuclein in the substantia nigra 60 days after injury.29
Recently, studies in humans have begun to replicate some
of these findings. Alpha-synuclein is elevated in cerebrospi-
nal fluid of TBI patients compared to controls during the
week following injury, and the degree of elevation is highly
predictive of survival.30 Among patients who die after
TBI, abundant alpha-synuclein deposition may be seen
within injured axons.31 A preliminary autopsy analysis
from the Adult Changes in Thought study that explored
associations between an array of dementia-related neuropa-
thologies and prior history of TBI among 525 patients
(107 with TBI) found that alpha-synuclein was the only
dementia-related neuropathology that was significantly
associated with TBI history.32 Small studies in clinical
populations have reported parkinsonism immediately fol-
lowing severe TBI that is sometimes dopamine respon-
sive33 and have identified functional magnetic resonance
imaging abnormalities in motor networks among patients
with post-traumatic parkinsonism that mirror those
reported in idiopathic PD.34 Post-traumatic parkinsonism,
however, may be transient and is hypothesized to be pri-
marily due to traumatic axonal disruption of nigrostriato-
frontal pathways. Among those cases that become chronic
or progressive, it is conceivable that neurodegenerative
pathology may be a contributing factor. This hypothesis,
however, is currently speculative and requires further study.
Lastly, some have found that TBI exposure may synergize
with other environmental exposures, such as pesticides,2,28
or specific genes35,36 to increase risk for PD, suggesting
that certain subpopulations may be at particularly high
risk for post-TBI PD.
This study is limited by the use of inpatient and ED
administrative diagnostic codes, which may be poorly sen-
sitive or specific to PD diagnoses.37,38 Poor sensitivity, if
equal across groups, should not bias the relative magnitude
of the association. However, severe TBI or bodily trauma
may make a diagnosis of PD difficult due to the possibility
of post-traumatic motor or behavioral abnormalities that
may complicate assessment. Thus some degree of bias in
ANNALS of Neurology
992 Volume 77, No. 6
diagnostic sensitivity across groups cannot be entirely ruled
out. Given the constraints of this administrative data set,
we were unable to validate PD diagnoses via expert review
of medical records or to develop complex algorithms to
include only diagnoses rendered by experts or to account
for medication use.38 Thus, the possibility of misdiagnosis
in this study underscores the critical importance of con-
firming these findings in large-scale prospective studies,
ideally with autopsy confirmation. The study is addition-
ally limited by lack of information regarding medical his-
tory (including prior TBI history) prior to the study
period, lack of detailed information regarding acute man-
agement of TBI such as medications and surgical interven-
tions, the relatively short 5- to 7-year follow-up duration,
inability to censor at death or loss to follow-up for any rea-
son, lack of outpatient data, and possible selection bias if
patients who present to the hospital for TBI differ from
those who do not seek medical care.39 Additionally, by
using a trauma control group, we essentially controlled for
any additional deleterious systemic effects of trauma on
the nervous system that could potentially independently
increase risk of PD. Thus, if NTT itself increases risk for
PD, then the risk of PD following TBI may be underesti-
mated in this study. Lastly, while the use of a NTT control
group may reduce confounding, the possibility for residual
confounding remains. Assault was a more common mecha-
nism of injury and alcohol disorders/dependence were
more common baseline comorbidities among TBI patients
compared to NTT patients. Although we adjusted for
these (and many other) potential confounders, we cannot
exclude the possibility that some residual unmeasured con-
founders exist (eg, a behavior that may lead a person to be
more likely to sustain a TBI vs an NTT and that may also
be an independent risk factor for PD). Despite these limi-
tations, we assert that the careful design of this study as
well as the robustness of the multiple additional analyses
and identification of a dose response support a causal asso-
ciation. We propose that future studies of neurodegenera-
tive disease using this data set may be appropriate if either
the outcome or predictor of interest is well suited to an
inpatient or ED diagnosis (as in the case of incident TBI)
and if the investigators carefully consider the above
limitations.
Conclusion
We report that among middle-aged and older trauma
patients presenting to an ED or inpatient setting, a TBI
results in a 44% increased risk of PD compared to a
trauma to the rest of the body over a follow-up period of
just 5 to 7 years. Based on our careful study design and
extensive secondary analyses, this result is almost cer-
tainly not solely due to reverse causation or confounding.
Furthermore, in combination with our prior study that
identified a 26% increased risk of dementia after TBI
versus NTT in this population,8 our results suggest that
TBI is an important independent risk factor for a variety
of neurodegenerative syndromes. Whether these post-TBI
syndromes are primarily subserved by typical dementia
or PD neuropathologies or may be partially or wholly
due to unique TBI-specific neuropathology, such as has
been documented in patients subjected to repeated TBI
who have chronic traumatic encephalopathy, deserves fur-
ther study. It is important to note that the vast majority
of TBI patients in this study did not develop PD. This
finding suggests that there must be multiple additional
risk or protective factors that determine susceptibility or
resilience to post-TBI neurodegeneration. Thus, it is
imperative for future studies to continue to elucidate the
underlying mechanisms and additional risk factors for
post-TBI neurodegenerative disease to inform treatment
and prevention in this high-risk population. Lastly, as the
cause of trauma in this study was overwhelmingly due to
falls, there is critical importance for fall prevention in
middle-aged and older adults not only as a means to pre-
vent bodily injury but potentially as a means to prevent
neurodegenerative diseases such as dementia and PD.
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